{"address1": "Building No. 5", "address2": "MATAM Advanced Technology Park", "city": "Haifa", "zip": "3508409", "country": "Israel", "phone": "972 74 710 8600", "website": "https://www.pluri-biotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company's product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle injuries following hip fracture, acute respiratory distress syndrome due to COVID-19, peripheral artery disease, intermittent claudication, and critical limb ischemia; PLX-R18, is composed of fetal MSC like cells originating from the placenta for the treatment of hematopoietic complications of the H-ARS, and phase I trial to treat hematopoietic cell transplantation; and allogeneic MAIT cell therapy platform. It also offers cell manufacturing services; cell-based coffee; and develops and commercializes cultivated meat products. The company operates in the field of regenerative medicine, food-tech, CDMO, and agtech. It has collaboration agreement with Bar-Ilan University to advance cancer immunotherapy for solid tumors. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yaacov  Yanay", "age": 53, "title": "President, CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 342479, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Liat  Zalts", "age": 40, "title": "Chief Financial Officer & Treasurer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lior  Raviv", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arthur  Machlenkin Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Efrat  Livne-Hadass", "title": "Chief Wellbeing Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Orly  Amiran", "title": "Chief Quality Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Efrat  Kaduri", "title": "Chief Business Development Officer of Pharma", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nimrod  Bar Zvi", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.35, "open": 4.3, "dayLow": 4.2001, "dayHigh": 4.33, "regularMarketPreviousClose": 4.35, "regularMarketOpen": 4.3, "regularMarketDayLow": 4.2001, "regularMarketDayHigh": 4.33, "payoutRatio": 0.0, "beta": 1.762, "forwardPE": -13.030303, "volume": 4342, "regularMarketVolume": 4342, "averageVolume": 10146, "averageVolume10days": 3680, "averageDailyVolume10Day": 3680, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 30087704, "fiftyTwoWeekLow": 4.07, "fiftyTwoWeekHigh": 6.6, "priceToSalesTrailing12Months": 44.377144, "fiftyDayAverage": 4.4742, "twoHundredDayAverage": 5.00025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 43181704, "profitMargins": 0.0, "floatShares": 3030951, "sharesOutstanding": 6997140, "sharesShort": 18048, "sharesShortPriorMonth": 30041, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0026, "heldPercentInsiders": 0.42569, "heldPercentInstitutions": 0.10378, "shortRatio": 2.34, "shortPercentOfFloat": 0.0027, "impliedSharesOutstanding": 7143590, "bookValue": -1.442, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -19860000, "trailingEps": -3.68, "forwardEps": -0.33, "lastSplitFactor": "1:8", "lastSplitDate": 1711929600, "enterpriseToRevenue": 63.69, "enterpriseToEbitda": -2.011, "52WeekChange": -0.18095237, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 4.3, "recommendationKey": "none", "totalCash": 21313000, "totalCashPerShare": 3.046, "ebitda": -21468000, "totalDebt": 29296000, "quickRatio": 4.832, "currentRatio": 5.038, "totalRevenue": 678000, "revenuePerShare": 0.125, "returnOnAssets": -0.37492, "returnOnEquity": -11.0259495, "grossProfits": 474000, "freeCashflow": -11713875, "operatingCashflow": -17207000, "revenueGrowth": 0.762, "grossMargins": 0.69912004, "ebitdaMargins": 0.0, "operatingMargins": -26.79459, "financialCurrency": "USD", "symbol": "PLUR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1743537600, "marketState": "PRE", "regularMarketChangePercent": -1.1494187, "regularMarketPrice": 4.3, "shortName": "Pluri Inc.", "longName": "Pluri Inc.", "exchange": "NCM", "messageBoardId": "finmb_6124664", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "regularMarketChange": -0.049999714, "regularMarketDayRange": "4.2001 - 4.33", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 10146, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.05651106, "fiftyTwoWeekRange": "4.07 - 6.6", "fiftyTwoWeekHighChange": -2.2999997, "fiftyTwoWeekHighChangePercent": -0.3484848, "fiftyTwoWeekChangePercent": -18.095238, "dividendDate": 1564012800, "earningsTimestamp": 1739307600, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.68, "epsForward": -0.33, "fiftyDayAverageChange": -0.17419958, "fiftyDayAverageChangePercent": -0.038934242, "twoHundredDayAverageChange": -0.7002497, "twoHundredDayAverageChangePercent": -0.14004293, "priceToBook": -2.9819696, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Pluristem Therapeutics Inc.", "nameChangeDate": "2025-04-01", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1056979800000, "displayName": "Pluri", "trailingPegRatio": null}